Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYou can drink wine while taking Wegovy, but most people find alcohol affects them differently on semaglutide, and there are real clinical reasons to be cautious. Wegovy slows gastric emptying, which changes how quickly alcohol enters your bloodstream, and the medicine itself can lower your tolerance noticeably. These aren't reasons to stop drinking entirely, but they are reasons to think before you pour. Wegovy is a prescription-only medicine that requires clinical assessment; your prescriber is best placed to advise based on your individual health picture.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Yes, and the mechanism is straightforward. Semaglutide slows the rate at which your stomach empties, so food and drink take longer to move into your small intestine. Alcohol absorbed through the stomach wall arrives in the bloodstream at a different pace than you're used to. The practical result is that one glass may feel like one and a half. Many patients are caught off guard the first time.
There is also good evidence that GLP-1 receptor agonists like semaglutide can dampen the reward response to alcohol in the brain. Some people on Wegovy report finding wine less appealing than they did before, or feeling satisfied after a single glass where they'd previously have had two. This is not a guaranteed effect, and it doesn't mean the medicine makes alcohol safe to drink in large amounts. It means your relationship with alcohol may shift during treatment in ways worth paying attention to.
A question our prescribers hear most weeks is whether Wegovy can be used specifically to cut down on drinking. That's a separate clinical conversation. For now, the licensed purpose of the medicine is weight management alongside lifestyle changes, and its effects on alcohol craving, while interesting, are not yet a licensed indication in the UK.
The NHS notes that nausea and vomiting are among the most common side effects of semaglutide, particularly after starting treatment or moving to a higher dose. Alcohol is a gastric irritant. Put the two together and the likelihood of feeling genuinely unwell rises. That's not a scare story; it's physiology.
The more serious concern involves pancreatitis. The MHRA issued a Drug Safety Update in January 2026 confirming acute pancreatitis as a known, if infrequent, risk with GLP-1 medicines including semaglutide. Heavy alcohol consumption is itself one of the most common triggers for pancreatitis. The combination of both risk factors in the same person is something prescribers take seriously. If you develop severe stomach pain that radiates towards your back, with or without vomiting, get medical help promptly rather than waiting it out.
Blood sugar is another consideration. Semaglutide affects glucose regulation, and alcohol can unpredictably lower blood sugar, particularly if you're not eating alongside it. For people also managing type 2 diabetes, this matters more; if you want to understand how Wegovy relates to diabetes, that topic is covered separately.
For most people, the answer is yes, with some adjustments. Clinical guidance does not require total abstinence while on semaglutide. The NHS semaglutide guidance advises limiting alcohol during treatment and discussing your drinking habits with your prescriber, particularly if you drink regularly.
Practically, that means a glass of wine at dinner is a different conversation from several glasses on an empty stomach. Eating something before or alongside drinking, staying hydrated, and going more slowly than usual are sensible adjustments that most people on Wegovy land on by themselves after the first experience. Starting treatment is a reasonable moment to reassess how much you drink in general, not as a moral exercise but because the medicine changes how your body responds.
The calorie dimension is also real. Alcohol provides little nutritional value and can stimulate appetite in some people despite the appetite-suppressing effect of the medicine. If progress has plateaued, overall alcohol intake during Wegovy treatment is one of the first practical questions worth revisiting. For a broader look at how the medicine is priced and what treatment involves, the Wegovy cost page sets that out plainly.
Tell your prescriber. That's the short answer. If you feel more intoxicated than your intake warrants, feel sick quickly, or notice your tolerance has dropped significantly, those are worth flagging at your next clinical review rather than quietly adapting around them.
Certain situations call for more urgent attention. Severe, persistent nausea or vomiting after drinking that leads to dehydration needs medical assessment because dehydration on GLP-1 treatment can affect kidney function. Severe abdominal pain, as noted above, warrants same-day medical attention. Suspected side effects from any medicine can be reported directly to the MHRA via the Yellow Card scheme.
If alcohol is a significant part of your life and you're unsure how to approach treatment, the consultation is exactly the right place to raise it. Alcohol questions on semaglutide broadly come up regularly, and if you are specifically wondering about whether wine is safe to drink while taking Wegovy, that is covered in detail to help you make an informed choice. Speak to our prescribers through a free consultation if you'd like to discuss whether Wegovy is right for you.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.